Resources from the same session
What benefit can we expect from emerging targeted agents including ICI to improve survival?
Presenter: Margaret Tempero
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Presentation
What are the biological reasons for treatment resistance in pancreatic adenocarcinoma?
Presenter: David Chang
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Presentation
Webcast
How can surgery improve resectability criteria?
Presenter: Massimo Falconi
Session: ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival?
Resources:
Presentation
Webcast